Finding Common Ground Across the Psychosis Spectrum

2012 Annual Meeting in Tampa, FL, April 29-May 2

Making Sense of Antidepressants: An Evidence-Based Approach to the Controversies

The controversies surrounding the use of antidepressants in the treatment of depressive disorders have rocked the world of psychiatry. From black box warnings to heated debates about efficacy in leading medical journals, this topic is sure to be timely and thought provoking. Nassir Ghaemi, MD, MPH will present Making Sense of Antidepressants: An Evidence-Based Approach to the Controversies on Sunday. Dr. Ghaemi is a world renowned leader in the treatment of mood disorders and author of A First-Rate Madness: Uncovering the Links Between Leadership and Mental Illness. After his presentation, you will have the chance to meet with Dr. Ghaemi and purchase a signed copy of this provocative book! Right now you can watch an interview with Dr. Ghaemi on The Colbert Report.

learn more

Finding Common Ground Across the Psychosis Spectrum

Log in for full access to this session if you are registered.

Session Summary

Previously, schizophrenia and bipolar disorder have been classified as two separate diagnoses in the practice of psychiatry. However, several findings recently have called into question whether these disorders are etiologically distinct. Family and twin studies have established that schizophrenia and bipolar disorder are familial and heritable phenotypes with shared genetic factors. Both disorders also share key clinical features including psychosis, neurocognitive impairment, and suicidality. During this presentation, Roy Perlis, MD, MSc will discuss recent findings in genetic studies of schizophrenia and bipolar disorder, as well as examine their implications on diagnostic tools and treatment. Plan to attend this session to gain insight into the future role of genetics in psychiatry.

Faculty Information

Roy Perlis, MD MSc

View biographical information and disclosures

Roy Perlis, MD MSc
Director, Center for Experimental Drugs and Diagnostics Department
Harvard Medical School

Dr. Roy Perlis is Director of the Center for Experimental Drugs and Diagnostics in the Department of Psychiatry and the Center for Human Genetic Research, Massachusetts General Hospital, and Associate Professor of Psychiatry at Harvard Medical School. He also directs the Clinical Team at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, and has served as consultant to the APA’s bipolar treatment guidelines workgroup.

Dr. Perlis earned his BSc in neuroscience from Brown University followed by an MD at Harvard Medical School and MSc in biostatistics at the Harvard School of Public Health. He completed residency and chief residency at MGH and McLean Hospital, and served as a research fellow in the mood disorders before joining the faculty. He created the laboratory of psychiatric pharmacogenomics and subsequently served as medical director of the MGH Bipolar Disorder Clinic and Research Program. In 2011 he launched the CEDD in an effort to speed the translation of bench science to clinical applications.

Dr. Perlis’ research focuses on treatment-resistant mood disorders, and on stratification of risk in psychiatry, from both a clinical and genetic perspective. Ongoing work by his group includes proof-of-concept trials of novel therapeutics as well as pharmacogenomic investigations and development of cellular models of disease. For his work in the STAR*D and STEP-BD cohorts he was awarded the DBSA’s Klerman Young Investigator Award in 2011; he has previously been the recipient of awards from NARSAD, the American Philosophical Society, the Sidney R. Baer, Jr. Foundation, and the Bowman Family Foundation, as well as departmental awards for teaching and research mentorship. His work is supported by funding from NIMH and the National Science Foundation.

Consultant:

Dr. Perlis has received consulting fees from RID Ventures, Proteus Biomedical, and Genomind LLC Dr. Perlis receives royalties from Concordant Rater Systems (now Medco)

Learning Objectives

Review recent findings from genetic and family studies of schizophrenia and bipolar disorder.
Examine the rationale for distinguishing bipolar disorder and schizophrenia.
Discuss the implications for course and treatment of bipolar disorder versus schizophrenia.
Describe efforts to identify diagnostic tools for bipolar disorder and schizophrenia.

Continuing Education Credit

Activity Date: 04/30/2012
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-12-006-L04-P (Knowledge)
ACCME: 1 AMA PRA Category 1 Credit(s)™
Nursing Credit Reminder: Note that ACPE and ACCME credit is accepted for certification renewal.

View complete continuing education credit details

ACPE Credit

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012 Annual Meeting will provide up to 14 contact hours (1.4 CEUs) of knowledge- and application-based continuing education credit from CPNP approved programming. The pre-meeting workshop is provided for an additional 7 contact hours (0.7 CEUs) and when combined with all other CPNP programming, allows for a maximum achievable 18 contact hours (1.8 CEUs). Industry supported symposia offered at the Annual Meeting offer additional ACPE credit.

To receive a statement of credit, participants must verify their attendance at the programming and complete evaluations and self-assessment questions. ACPE statements of credit will be retrieved by participants online on the CPNP website within one month following the event.

CME Credit

Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. The University of Arizona College of Medicine at the Arizona Health Sciences Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Arizona College of Medicine at the Arizona Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website): “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.

Course Requirements

This session is presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides is provided online. Access to the online PDF content is available to participants indefinitely although ACPE credit is available only through the Annual Meeting. To obtain continuing education credit, attendees of this session must confirm their attendance by completing a session evaluation within two weeks after the session. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed. CME statements will be issued by the end of June 2012 by the University of Arizona.

View System Requirements in Order to View the Presentation and Complete Course Requirements

Minimum:

Internet Explorer 6+, Firefox 2+ or Safari 3+
1024x768 resolution or greater
Adobe Flash Player 8+
512MB RAM
Any Operating System capable of the above requirements

Recommended:

Internet Explorer 7+, Firefox 3+ or Safari 3+
1280x768 resolution or greater
Adobe Flash Player 10+
Windows XP/2000/Vista and Mac OS 10.4 or better
512MB of RAM for Windows XP or Mac OS
1GB of RAM for Windows Vista